Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Dino Dujmović"'
Autor:
Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić, Martina Morić-Perić, Dino Dujmović, Ivo Radman, Barbara Dreta, Snježana Dotlić, Ivana Ilić, Lea Galunić Bilić, Margareta Dobrenić, Marko Kralik, Igor Aurer
Publikováno v:
Medicina, Vol 60, Iss 3, p 430 (2024)
Background and Objectives: eBEACOPP is the most effective chemotherapy regimen for younger patients with early unfavorable (EU) and advanced-stage (AS) Hodgkin lymphoma (HL), albeit with significant toxicities. The 14-day/cycle prednisone course cont
Externí odkaz:
https://doaj.org/article/aa353efaeaa543cd9c08ecf8a014fba1
Autor:
Ida Hude Dragičević, Sandra Bašić-Kinda, Dino Dujmović, Ivo Radman, Barbara Dreta, Sandra Dotlić, Lea Galunić-Bilić, Margareta Dobrenić, Marko Kralik, Pavle Rončević, Igor Aurer
Publikováno v:
HemaSphere, Vol 6, Pp 8-8 (2022)
Externí odkaz:
https://doaj.org/article/cbf2c62b30d0467a8e3ae6b76a4ca891
Autor:
Nadira Duraković, Zinaida Perić, Sandra Bašić Kinda, Lana Desnica, Dino Dujmović, Ivo Radman Livaja, Ranka Serventi Seiwerth, Igor Aurer, Radovan Vrhovac
Publikováno v:
Clinical Hematology International, Vol 3, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/cd5db7e76ca04e8f809d3a388da93dd5
Autor:
Vedran Premužić, Sandra Bašić-Kinda, Ivo Radman, Dino Dujmović, Ivana Ilić, Neno Živković, Lucija Maleta, Marko Kralik, Margareta Dobrenić, Lea Galunić-Bilić, Pavle Rončević, Marijo Vodanović, Igor Aurer
Publikováno v:
Medicine. 102:e33675
Autor:
Zinaida Peric, Nadira Duraković, Lana Desnica, Igor Aurer, Ivo Radman Livaja, Ranka Serventi Seiwerth, Dino Dujmović, Sandra Bašić Kinda, Radovan Vrhovac
Publikováno v:
Clinical Hematology International
Clinical Hematology International, Vol 3, Iss 3 (2021)
Clinical Hematology International, Vol 3, Iss 3 (2021)
Ishod alotransplantacije u Hodgkinovom limfomu ovisno o odgovoru na prethodno liječenje
Autor:
Zrinka Sertić, Lea Galunić-Bilić, Sandra Bašić-Kinda, Marko Kralik, Igor Aurer, Ivo Radman, Marijo Vodanović, Ida Hude, Dino Dujmović, Pavle Rončević, Ivana Ilić, Margareta Dobrenić
Currently, there is no consensus regarding optimal front-line treatment for younger high- risk patients with large B cell lymphoma. American recommendations list only R-CHOP as standard, while European also include R-ACVBP and R-CHOEP14. We have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a15bc80904c101fb77b90d02cc08c8a
https://doi.org/10.1007/s00277-020-04353-3
https://doi.org/10.1007/s00277-020-04353-3
Autor:
Sandra, Bašić-Kinda, Ivo, Radman, Dino, Dujmović, Ivana, Ilić, Marko, Kralik, Margareta, Dobrenić, Lea, Galunić-Bilić, Pavle, Rončević, Marijo, Vodanović, Zrinka, Sertić, Ida, Hude, Igor, Aurer
Publikováno v:
Annals of hematology. 100(6)
Currently, there is no consensus regarding optimal front-line treatment for younger high-risk patients with large B cell lymphoma. American recommendations list only R-CHOP as standard, while European also include R-ACVBP and R-CHOEP14. We have been
Autor:
Nadira Duraković, Dino Dujmović, Toni Matić, Ružica Lasan-Trčić, Ernest Bilić, Zrinko Šalek, Radovan Vrhovac, Sandra Bašić-Kinda
Publikováno v:
Liječnički vjesnik. 140:126-128
Autor:
Toni Matić, Zrinko Šalek, Radovan Vrhovac, Nadira Duraković, Ružica Lasan-Trčić, Sandra Bašić-Kinda, Dino Dujmović, Ernest Bilić
Publikováno v:
Liječnički vjesnik
Volume 140
Issue 3-4
Volume 140
Issue 3-4
Fanconijeva anemija (FA) rijetka je nasljedna bolest karakterizirana kongenitalnim anomalijama, progresivnim poremećajem funkcije koštane srži i predispozicijom za razvoj hematoloških i nehematoloških malignih boles-ti. Poremećaj funkcije košt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e35b390f4509000af6803fc4bb38fcde
https://doi.org/10.26800/lv-140-3-4-12
https://doi.org/10.26800/lv-140-3-4-12
Autor:
Lea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, Sandra Basic-Kinda, Dino Dujmovic, Marijo Vodanovic, Inga Mandac Smoljanovic, Slobodanka Ostojic Kolonic, Ruzica Galunic Cicak, Igor Aurer
Publikováno v:
Cancers, Vol 16, Iss 3, p 649 (2024)
(1) Background: This study aimed to examine the difference in efficacy and toxicity of involved-field (IFRT) and involved-site radiotherapy (ISRT) fields in infradiaphragmal aggressive non-Hodgkin lymphoma patients. (2) Methods: In total, 140 patient
Externí odkaz:
https://doaj.org/article/fa3dae2868e34ef0bf76105b6e373973